ABT Molecular Imaging

LOUISVILLE, TN · Founded 2005 · Medtech · Acquired

Automated radioisotope biomarker generator system for on-site production of PET imaging tracers ([18F]FDG and [18F]FLT)

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · advancedbiomarker.com

Sector: Medtech
Headquarters: LOUISVILLE, TN
Founded: 2005
Latest Form D: $750K, Aug 2014
Total capital: $23.3M

Federal grants: $3.3M; 4 awards · 2015–2017; Rank in peer group#205 of 477
Private capital raised: $19.9M; 10 Form D · last Aug 2014; 146 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 2; 5 pending · first 2017; Rank in peer group#118 of 477

Capital timeline

Latest events

Jun 2017Federal grantHealth and Human S · Phase II · Development of Tumor Proliferation PET Tracer FLT using a Low Cost Single Dose Automatic Production and Quality Control Biomarker Generator System$712K
Jun 2016Federal grantHealth and Human S · Phase II · Development of Tumor Proliferation PET Tracer FLT using a Low Cost Single Dose Automatic Production and Quality Control Biomarker Generator System$1.6M
Jun 2016Federal grantHealth and Human S · Phase II · Development of Tumor Proliferation PET Tracer FLT using a Low Cost Single Dose Automatic Production and Quality Control Biomarker Generator System$843K
May 2015Federal grantHealth and Human S · Phase II · Development of Tumor Proliferation PET Tracer FLT using a Low Cost Single Dose Automatic Production and Quality Control Biomarker Generator System$223K
Aug 2014Private capital raisedForm D · SEC · 10th filing$750K
May 2014Private capital raisedForm D · SEC · 9th filing$775K
Apr 2014Private capital raisedForm D · SEC · 8th filing$800K
Feb 2014Private capital raisedForm D · SEC · 7th filing$500K
Dec 2013Private capital raisedForm D · SEC · 6th filing$401K
Sep 2012Private capital raisedForm D · SEC · 5th filing$6.1M
Aug 2012Private capital raisedForm D · SEC · 4th filing$150K
Mar 2012Private capital raisedForm D · SEC · 3rd filing$500K
Jun 2011Private capital raisedForm D · SEC · 2nd filing$4M
Oct 2009Private capital raisedForm D · SEC · 1st filing$6M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 477 peers

Line = median

Medtech · Device

Federal grants#205 · top 43%
Granted patents#118 · top 25%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

Ronald NuttResearcherDirectorLinked by 1 patent
Bengt LangstromDirectorNamed in SEC Form D filings
Dennis DoughertyDirectorNamed in SEC Form D filings
Henry WagnerDirectorNamed in SEC Form D filings
Lynda NuttExecutive OfficerNamed in SEC Form D filings
Michael TemplinExecutive OfficerNamed in SEC Form D filings

Show all 14 people

Peter KingmaExecutive Officer, DirectorNamed in SEC Form D filings
Rik VandevenneDirectorNamed in SEC Form D filings
Robert A VincillExecutive OfficerNamed in SEC Form D filings
Rurik Gerard VandevenneDirectorNamed in SEC Form D filings
Thomas E WelchExecutive Officer, DirectorNamed in SEC Form D filings
Vincill A. RobertExecutive OfficerNamed in SEC Form D filings
Welch E. ThomasExecutive Officer, DirectorNamed in SEC Form D filings
William McInnesDirectorNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 7

Oct 23, 2018GrantedDose Synthesis Card For Use With Automated Biomarker Production SystemUSPTOUS 10,109,385
Jun 20, 2017GrantedRadioisotope Target AssemblyUSPTOUS 9,686,851
PendingAutomated Quality Control System For RadiopharmaceuticalsUSPTOApplication PCTUS2016016952

Show all 7 patent records

Dose Synthesis Card For Use With Automated Biomarker Production SystemOct 23, 2018 · US 10,109,385Granted
Radioisotope Target AssemblyJun 20, 2017 · US 9,686,851Granted
Automated Quality Control System For RadiopharmaceuticalsApplication PCTUS2016016952Pending
Automated Radiopharmaceutical Production And Quality Control SystemApplication PCTUS2016016964Pending
Dose Synthesis Card For Use With Automated Biomarker Production SystemApplication PCTUS2016016926Pending
Radioisotope Target AssemblyApplication PCTUS2012058291Pending
Improved Biomarker GeneratorApplication PCTUS2011021844Pending

BIOIMAGINIX LLCSimilar federal contract value in Medtech · null in contracts
PanTher Therapeutics, Inc.Similar federal contract value in Medtech · null in contracts
NESHER TECHNOLOGIES INCSimilar federal contract value in Medtech · null in contracts
PROTEOWISE, INC.Similar federal contract value in Medtech · null in contracts
SEARCHLIGHT SENSORSSimilar federal contract value in Medtech · null in contracts
TECHNOLOGY COMMERCIALIZATION PARTNERS, LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.